References
- Yu W, Yang B, Xu S, Gao Y, Huang Y, Wang Z. Diabetic retinopathy and cardiovascular disease: a literature review. Diabetes Metabol Syndr Obes. 2023;16:4247–4261. doi:10.2147/DMSO.S438111
- Sörensen BM, Houben AJ, Berendschot TT, et al. Prediabetes and type 2 diabetes are associated with generalized microvascular dysfunction: the Maastricht study. Circulation. 2016;134(18):1339–1352. doi:10.1161/CIRCULATIONAHA.116.023446
- Brownrigg JR, Hughes CO, Burleigh D, et al. Microvascular disease and risk of cardiovascular events among individuals with type 2 diabetes: a population-level cohort study. Lancet Diabetes Endocrinol. 2016;4(7):588–597. doi:10.1016/S2213-8587(16)30057-2
- Kawasaki R, Cheung N, Islam FM, et al. Is diabetic retinopathy related to subclinical cardiovascular disease? Ophthalmology. 2011;118(5):860–865. doi:10.1016/j.ophtha.2010.08.040
- Simo R, Baneras J, Hernandez C, et al. Diabetic retinopathy as an independent predictor of subclinical cardiovascular disease: baseline results of the PRECISED study. BMJ Open Diabetes Res Care. 2019;7(1):e000845. doi:10.1136/bmjdrc-2019-000845
- Modjtahedi BS, Wu J, Luong TQ, Gandhi NK, Fong DS, Chen W. Severity of diabetic retinopathy and the risk of future cerebrovascular disease, cardiovascular disease, and all-cause mortality. Ophthalmology. 2021;128(8):1169–1179. doi:10.1016/j.ophtha.2020.12.019
- Grunwald JE, Pistilli M, Ying GS, et al. Progression of retinopathy and incidence of cardiovascular disease: findings from the Chronic Renal Insufficiency Cohort Study. Br J Ophthalmol. 2021;105(2):246–252. doi:10.1136/bjophthalmol-2019-315333